v3.26.1
Unaudited Consensed Consolidated Statements of Cash Flows
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Cash flows from operating activities:        
Net loss $ (9,610) $ (5,645) $ (12,199) $ (10,065)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 674 484 1,047 1,005
Amortization of finance lease right-of-use assets 47 44 211 226
Stock-based compensation expense 1,099 1,239 1,941 383
Non-cash operating lease expense 3 86 189 164
Non-cash finance lease interest expense 30 51 114 149
Deferred tax asset (163)    
Change in fair value of convertible notes     1,492
Change in operating assets and liabilities:        
Accounts receivable (362) 636 764 (651)
Contract assets (140) (38) (100) 65
Prepaid expenses and other current assets (124) (395) 72 (76)
Other assets (27) (120) (120) (8)
Accounts payable 667 56 542 181
Accrued expenses and other current liabilities (262) (16) 273 230
Deferred revenue 349 (59) 579
Operating lease liabilities 173 (128) (18) (164)
Contract liabilities     (576) 562
Deferred tax assets     (29) 17
Net cash used in operating activities (7,646) (3,805) (7,889) (6,490)
Cash flows from investing activities:        
Purchases of property and equipment (1,410) (359) (2,008) (132)
Net cash flow used in investing activities (1,410) (359) (2,008) (132)
Cash flows from financing activities:        
Proceeds from issuance of Series A-2 preferred stock 9,990 10,000 11,410
Proceeds from issuance of Series X preferred stock 257 18,988
Payment of deferred offering costs (1,240) (45)
Proceeds from the exercise of stock options 40 76 89 4
Principal payment on finance leases (280) (150) (653) (471)
Proceeds from issuance of convertible note     1,150
Payment of issuance costs related preferred stock     (127) (485)
Net cash (used in) provided by financing activities (1,223) 9,916 28,252 11,608
Effect of exchange rate changes on cash 427 104 28 44
Net (decrease) increase in cash (9,851) 5,856 18,383 5,030
Cash at beginning of year 27,967 9,584 9,584 4,554
Cash at end of period 18,116 15,440 27,967 9,584
Cash, end of period 18,116   27,967 9,427
Restricted cash, included in other assets, end of period     157
Total cash and restricted cash, end of period 18,116 15,440 27,967 9,584
Supplemental disclosure of cash flow information:        
Deferred offering costs in accrued expenses 1,410 10    
Reclassification of finance right-of-use asset to property and equipment upon purchase 298    
Property and equipment in accrued expenses $ 6    
Cash paid for income taxes    
Supplemental disclosure of non-cash investing and financing activities:        
Property and equipment in accounts payable     5 122
Deferred offering costs in accounts payable and accrued expenses     813
Operating lease right of use asset obtained in exchange for lease liabilities     1,472
Reclassification of finance right-of-use asset to property and equipment upon purchase of leased equipment     442
Conversion of convertible notes into Series A-2 and Series SA-2 preferred stock     $ 13,528